2017年度
 附属病院がんセンター
■ 当該年度研究業績数一覧表
研究者名 論文 著書 学会発表 その他
発表
和文英文 和文英文 国内国際














佐竹 悠良   学長特命准教授
 0 0 2 5  0 0 0 0  0  0  0  0  0  0
 0 0 2 5  0 0 0 0  0  0  0  0  0  0
■ 学術雑誌
原著
1. Satake H, Kondo M, Mizumoto M, Kotake T, Okita Y, Ogata T, Hatachi Y, Yasui H, Miki A, Imai Y, Ichikawa C, Murotani K, Kotaka M, Kato T, Kaihara S, Tsuji A:  Phase I study of neoadjuvant chemotherapy with capecitabine and oxaliplatin for locally advanced gastric cancer.  Anticancer research  37 (7) :3703 -3710 , 2017
2. Yanagimoto H, Toyokawa H, Sakai D, Wada H, Satoi S, Yamamoto T, Nagano H, Toyoda M, Ajiki T, Satake H, Tsuji A, Miyamoto A, Tsujie M, Takemura S, Yanagihara K, Ioka T:  A phase I study for adjuvant chemotherapy of gemcitabine plus S-1 in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1202).  Cancer chemotherapy and pharmacology  81 (3) :461 -468 , 2018
3. Ando K, Emi Y, Suenaga T, Hamanoue M, Maekawa S, Sakamoto Y, Kai S, Satake H, Shimose T, Shimokawa M, Saeki H, Oki E, Sakai K, Akagi Y, Baba H, Maehara Y; Kyushu Study Group of Clinical Cancer (KSCC):  A prospective study of XELIRI plus bevacizumab as a first-line therapy in Japanese patients with unresectable or recurrent colorectal cancer (KSCC1101).  International journal of clinical oncology  22 (5) :913 -920 , 2017
4. Satake H, Yasui H, Kotake T, Okita Y, Hatachi Y, Kotaka M, Kato T, Tsuji A:  First-line chemotherapy with capecitabine/ oxalipatin for advanced gastric cancer: A phase I study.  Molecular and clinical oncology  7 (3) :347 -350 , 2017
5. Moriwaki T, Fukuoka S, Taniguchi H, Takashima A, Kumekawa Y, Kajiwara T, Yamazaki K, Esaki T, Makiyama C, Denda T, Satake H, Suto T, Sugimoto N, Enomoto M, Ishikawa T, Kashiwada T, Sugiyama M, Komatsu Y, Okuyama H, Baba E, Sakai D, Watanabe T, Tamura T, Yamashita K, Gosho M, Shimada Y:  Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study.  The oncologist  23 (1) :7 -15 , 2018
症例報告
1. Ogata T, Satake H, Ogata M, Hatachi Y, Yasui H:  Oxaliplatin-Induced Hyperammonemic Encephalopathy in a Patient with Metastatic Pancreatic Cancer: A Case Report.  Case reports in oncology  10 (3) :885 -889 , 2017
2. Ogata T, Satake H, Ogata M, Hatachi Y, Yasui H:  Hyperprogressive Disease in the Irradiation Field after a Single Dose of Nibolumab for Gastric Cancer: A Case Report.  Case reports in oncology  11 (1) :143 -150 , 2018